Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(interferon beta 1a)
2,002 results
  • Teriflunomide -- Benefit Assessment According to §35a Social Code Book V [BOOK]
  • BOOKInstitute for Quality and Efficiency in Health Care (IQWiG): Cologne, Germany
  • Institute for Quality and Efficiency in Health Care
  • The aim of this report is to assess the added benefit of teriflunomide in comparison with the appropriate comparator therapy (ACT) in adult patients with relapsing remitting multiple sclerosis (RRMS)...
  • Fingolimod -- Benefit Assessment According to §35a Social Code Book V [BOOK]
  • BOOKInstitute for Quality and Efficiency in Health Care (IQWiG): Cologne, Germany
  • Institute for Quality and Efficiency in Health Care
  • In the benefit assessment fingolimod was compared with: glatiramer acetate in patients with highly active relapsing-remitting multiple sclerosis (RRMS), who have failed to respond to a full and adequ...
  • Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. [Review]
  • CDCochrane Database Syst Rev 2016 Nov 15; 11:CD008630
  • Pritchard J, Hughes RA, … Brassington R
  • CONCLUSIONS: The quality of the evidence was very low. Three small RCTs, comparing interferon beta-1a or brain-derived neurotrophic factor with placebo, and cerebrospinal fluid filtration with plasma exchange, showed no significant benefit or harm for any of the interventions. A fourth small trial showed that the Chinese herbal medicine, tripterygium polyglycoside, hastened recovery in people with GBS to a greater extent than corticosteroids, but this result needs confirmation. We were unable to draw any useful conclusions from the few observational studies we identified.
New Search Next